Skip to content
buyWeak cluster of 4

Dannielle Appelhans bought $18k of GBIO

director at Generation Bio Co.. 12,000 shares at an average of $1.50, traded Dec 4, 2023, filed Dec 6, 2023.

Conviction score
38
Value
$18k
12,000 shares
Holdings after
12,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $18k at market
    0
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    No price history yet
    0
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001415889-23-015929, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 4, 2023POpen-market purchase
Common Stock
+12,000$1.50$18k12,000Dec 6, 2023

Related signals

Other insiders at Generation Bio Co. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
37Weak
GBIObuy
Generation Bio Co.
Anthony G. Quinn
director
$203k
210,791 shares
+238%
10Weak
GBIOsell10b5-1
Generation Bio Co.
Antoinette Paone
CHIEF OPERATING OFFICER
$18k
6,719 shares
-33%
18Weak
GBIOsell 210b5-1
Generation Bio Co.
Antoinette Paone
CHIEF OPERATING OFFICER
$3,961
2,445 shares
-30%
3Weak
GBIOsell 210b5-1
Generation Bio Co.
Phillip Samayoa
CHIEF STRATEGY OFFICER
$3,961
2,445 shares
-2%
45Moderate
GBIObuy 4
Generation Bio Co.
Dannielle Appelhans
director
$14k
8,000 shares
+67%
51Moderate
GBIObuy 4
Generation Bio Co.
Donald William Nicholson
director
$144k
100,000 shares
+88%
48Moderate
GBIObuy 4
Generation Bio Co.
Anthony G. Quinn
director
$125k
88,495 shares
-
58Moderate
GBIObuy 4
Generation Bio Co.
Charles A Rowland Jr
director
$478k
342,960 shares
+179%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dannielle Appelhans bought $18k of GBIO | InsiderTell